Published in AIDS Weekly, July 15th, 2002
The tests, involving thousands of volunteers, were delayed as more time was needed to prepare for the unusually large project, said Dr. Supachai Rerks-Ngarm, a Thailand Health Ministry official and project director.
The 5-year trial will use a combination of two vaccines, one from the French pharmaceutical company Aventis Pasteur and one from VaxGen of the United States. The combination will be given to 16,000 uninfected volunteers ages 20-30 in two eastern Thai provinces, Rayong and Chonburi.
"We are waiting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.